title: [Disseminated melanoma cells in blood and bone marrow. Significance and detection by potential tumor markers].
abstract: As the majority of primary malignant melanomas can be cured by surgical excision, the prognosis of melanomas is dependent on whether tumor cells have disseminated orare capable of doing so at the time of surgery. A prospective and valid detection of this minimal residual disease is not currently possible. The most important known so-called markers of melanoma disease, tyrosinase, S100 and MIA, all are more likely to be present in patients with more advanced disease. A valid prognostic effect has only been shown for S100 in patients with already identified metastatic disease. Further prospective studies are required to determine the potential gain of information by routine determination of these markers in melanoma patients.
authors.affiliation: Hautklinik der Universität Heidelberg, Vosstrasse 2, 69115 Heidelberg.
authors.forename: V
authors.initials: V
authors.lastname: Waldmann
authors.forename: M
authors.initials: M
authors.lastname: Deichmann
authors.forename: A
authors.initials: A
authors.lastname: Jäckel
mesh_terms: D014408:Biomarkers, Tumor / Q000032:analysis*; D019046:Bone Marrow Neoplasms / Q000473:pathology / Q000556:secondary*; D006801:Humans; D008545:Melanoma / Q000473:pathology / Q000556:secondary*; D018365:Neoplasm, Residual / Q000473:pathology; D009360:Neoplastic Cells, Circulating / Q000473:pathology*; D011379:Prognosis; D012878:Skin Neoplasms / Q000473:pathology*
chemical_list: D014408:Biomarkers, Tumor